In December 2024, several generic versions of liraglutide (Victoza) for the treatment of type 2 diabetes became commercially available in the United States, while an authorized generic (AG) version launched in the United States in June 2024
The usual dose was 5 mg daily, and the primary end point a composite of cardiovascular death, MI or ischemic stroke, and the main secondary end point a composite of cardiovascular death, MI, stroke, hospitalization for unstable angina, coronary revascularization, or heart failure
However their performance will get worse over time and with usage, so people tend to just replace them every 2 to 3 years for optimal performance
What C-ratings really mean The C-rating on a LiPo battery tells you the maximum continuous current the pack can deliver
Effects appear within 30-60 minutes and persist for 4-6 hours
LOX-1 is responsible for binding, being internalized, and proteolytically degrading oxLDL but not acetylated LDL, and thus mediates foam cell formation in atherosclerotic plaques (35)
